Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZTW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,803
Award facts
- Contract value 100% obligated
- $31,802.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31.8K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of DOVATO 50-300 mg tablets (30-count units). The contract, awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, carries no set-aside designation and represents a competitively awarded transaction. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The company serves as a critical federal vendor with an extensive portfolio of medical product deliveries, primarily through its relationship with the Defense Logistics Agency and military healthcare systems. DOVATO is an HIV treatment medication, reflecting AmerisourceBergen's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its capability to meet federal procurement requirements in open competition.
Quick answers
Who was awarded contract SPE2DR26F4ZTW?
SPE2DR26F4ZTW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F4ZTW worth?
The government has obligated $31,803 on SPE2DR26F4ZTW.
Is contract SPE2DR26F4ZTW an order under another contract?
Yes. SPE2DR26F4ZTW is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZTW competed?
The extent of competition for SPE2DR26F4ZTW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award